Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Jefferies starts Nutrien stock coverage with buy, sets $62 price target

EditorAhmed Abdulazez Abdulkadir
Published 03/26/2024, 05:59 AM
Updated 03/26/2024, 05:59 AM
© Reuters.

On Tuesday, Jefferies initiated coverage on shares of Nutrien Ltd. (NYSE: NYSE:NTR), a major supplier of fertilizers and crop protection solutions, with a Buy rating. The firm has set a price target of $62.00 for the company's stock.

The new coverage by Jefferies highlights Nutrien's potential benefits from various long-term factors. According to the firm, Nutrien is well-positioned to leverage an upturn in consumer confidence, inventory restocking, climate-induced stress on crop pricing, and changes in nitrogen economics due to the energy transition.

Jefferies' assessment suggests that the forecasts for Nutrien might be on the conservative side, taking into account several challenges. These include obstacles to farm productivity, demographic shifts, and a diminishing competitive edge from U.S. shale production.

The price target of $62.00 implies that Jefferies sees a positive trajectory for Nutrien's stock value. This outlook is based on the company's strategic place in the market as a leading provider of essential agricultural inputs.

Nutrien's role in the agricultural sector is critical as it provides products that support crop growth and protection. The company's future performance is anticipated to be influenced by the aforementioned factors, which could impact global food production and commodity prices.

InvestingPro Insights

As Nutrien Ltd. (NYSE: NTR) captures the attention of Jefferies with a Buy rating, real-time data from InvestingPro further enriches the investment landscape. Nutrien's market capitalization stands at a robust $26.0 billion, underscoring its significant presence in the Chemicals industry. The company's Price to Earnings (P/E) ratio, a key indicator of its valuation, is currently at 20.76, with an adjusted P/E for the last twelve months as of Q4 2023 at 14.07. This suggests a possibly more attractive valuation relative to earnings than the raw P/E might imply.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro Tips highlight that Nutrien has demonstrated a commitment to shareholder returns, raising its dividend for 6 consecutive years, and the dividend yield is now at a generous 4.11%. Moreover, the company's management has been actively engaging in share buybacks, a move that can often signal confidence in the company's future prospects. However, analysts have tempered expectations with 5 of them revising their earnings estimates downwards for the upcoming period, indicating potential headwinds or a conservative outlook on future financial performance.

For investors contemplating a stake in Nutrien, these metrics and insights could be pivotal. To delve deeper into the company's financial health and future prospects, access more InvestingPro Tips for Nutrien at https://www.investing.com/pro/NTR. Remember to use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, and discover the full range of insights available, including numerous additional tips to guide investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.